Prolonged impact of COVID-19
First written in FY2022. 3 of 5 entries say "Mitigated", first in FY2023-Q2. Latest entry: FY2025.
The whole theme swung hardest in 2020: 103 of 175 companies on the "Worse" side.
- FY2025MitigatedAnnual report
「If such an infectious disease emerges, we will take measures to prevent infection, including establishing a structure that minimizes disruption to operations in line with government policy, such as working from home, staggered working hours, and encouraging remote meetings.」
The company continues to address infectious-disease risk, including similar diseases, through work-from-home arrangements, staggered hours, remote meetings, and cash-management measures. - FY2024ReframedAnnual report
「Although COVID-19 is on a declining trend, similar infectious diseases may emerge in the future. While it is currently difficult to quantify the risk, we recognize that there remains a substantial possibility that it will materialize.」
The risk disclosure has broadened from prolonged COVID-19 to infectious diseases generally, including similar diseases. - FY2023-Q3MitigatedAnnual report
「During the nine-month period ended in the third quarter, the Japanese economy showed signs of a gradual recovery and economic and social activity moved toward normalization following the reclassification of COVID-19 as a Class 5 infectious disease.」
The reclassification of COVID-19 as a Class 5 infectious disease is associated with a recovery trend and normalization of economic and social activity, reducing the constraints on business activity. - FY2023-Q2MitigatedAnnual report
「As various restrictions related to COVID-19 were eased, the economy showed signs of a gradual recovery and economic and social activity moved toward normalization.」
The easing of restrictions and normalization of economic and social activity indicate that COVID-19-related constraints on business activity have weakened. - FY2022First statedAnnual report
「If the spread of COVID-19 continues for an extended period, reduced orders, lower sales, lower profit margins, and longer collection periods caused by lost purchasing opportunities, deteriorating market conditions, and customers’ restraint in making new purchases could adversely affect our financial performance and financial position and slow our growth.」
The company describes the difficult-to-quantify risks of a prolonged infectious disease outbreak affecting consumption, orders, margins, collections, and product development.